thiazoles has been researched along with Ewing Sarcoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchamp, EM; Bell, JB; Blyth, GT; Clymer, J; Eckerdt, F; Goldman, S; Platanias, LC | 1 |
| Beck, JF; Becker, S; Blümel, L; Blumrich, A; Focke, K; Grauel, D; Hentschel, J; Krämer, OH; Marx, C; Schinkel, S; Sonnemann, J; Wittig, S | 1 |
| Boerman, OC; Fleuren, ED; Flucke, UE; Leenders, WP; Roeffen, MH; Schreuder, HW; van der Graaf, WT; Versleijen-Jonkers, YM; Vlenterie, M | 1 |
| Jove, R; Keschman, EA; Lee, FY; Letson, GD; Muro-Cacho, C; Pledger, WJ; Shor, AC; Trent, JC | 1 |
| Erlacher, M; Hilger, RA; Khanna, C; Konanz, C; Kontny, U; Lissat, A; Mendoza, A; Niemeyer, CM; Reichardt, W; Uhl, M; Werner, S | 1 |
| Cordero di Montezemolo, L; Crescenzio, N; Doria, A; Fandi, A; Foglia, L; Timeus, F | 1 |
6 other study(ies) available for thiazoles and Ewing Sarcoma
| Article | Year |
|---|---|
Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Imidazoles; Medulloblastoma; Mice, Nude; Protein Kinase Inhibitors; Sarcoma, Ewing; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Triazines; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2019 |
RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.
Topics: Antineoplastic Agents; Bone Neoplasms; Catechols; Cell Cycle Checkpoints; Cell Proliferation; HCT116 Cells; Humans; Mutation; Sarcoma, Ewing; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2015 |
Expression and clinical relevance of MET and ALK in Ewing sarcomas.
Topics: Adolescent; Adult; Anaplastic Lymphoma Kinase; Anilides; Child; Child, Preschool; Chromosome Aberrations; Crizotinib; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Inhibitory Concentration 50; Male; Middle Aged; Neoplasm Metastasis; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Recurrence; Sarcoma, Ewing; Tetrazolium Salts; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Dasatinib; Enzyme Activation; Humans; Neoplasm Invasiveness; Osteosarcoma; Protein Kinase Inhibitors; Pyrimidines; Rhabdomyosarcoma; Sarcoma, Ewing; Signal Transduction; src-Family Kinases; Thiazoles | 2007 |
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Topics: Animals; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Bisbenzimidazole; Blotting, Western; Busulfan; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Coloring Agents; G1 Phase; Indicators and Reagents; Injections, Intraperitoneal; Mice; Mice, Nude; Sarcoma, Ewing; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2008 |
In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Humans; Neuroblastoma; Protein Kinase Inhibitors; Pyrimidines; Sarcoma, Ewing; Thiazoles | 2008 |